Human leukocyte antigen (HLA)-E and HLA-F expression in gastric cancer.

Abstract:

:Human leukocyte antigen (HLA)-E and HLA-F are classified as non-classical HLA class Ib antigens. Ectopic HLA-E and HLA-F expression was recently detected in cancer cells; however, the clinical implication of their expression remains unknown. A total of 209 patients with gastric cancer were enrolled in this study. Immunohistochemistry was used to evaluate the expression of HLA-E and HLA-F in gastric cancer specimens. HLA-E and HLA-F expression were seen in the cell membrane. HLA-E and HLA-F expression significantly correlated with depth of invasion, nodal involvement, lymphatic invasion, and venous invasion. No significant correlation between HLA-E and HLA-F expression was found (p<0.05, r=0.24). The five-year survival rate of the HLA-E-positive group and HLA-F-positive group were significantly poorer than that of their respective negative groups. Combination of HLA-E and HLA-F made the p-value smaller than single analysis (p<0.009). This is the first report detailing a clinical implication of HLA-E and HLA-F expression simultaneously in gastric cancer. We identified that the HLA-E and HLA-F in gastric cancer independently affected clinical factors, including postoperative outcome. For HLA-E- or HLA-F-positive gastric cancer, we should settle on a treatment strategy that reinforces the host immune response.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Ishigami S,Arigami T,Okumura H,Uchikado Y,Kita Y,Kurahara H,Maemura K,Kijima Y,Ishihara Y,Sasaki K,Uenosono Y,Natsugoe S

subject

Has Abstract

pub_date

2015-04-01 00:00:00

pages

2279-85

issue

4

eissn

0250-7005

issn

1791-7530

pii

35/4/2279

journal_volume

35

pub_type

杂志文章
  • Pooled-analysis of Lipegfilgrastim Effectiveness and Safety Among Patients With Blood Malignancies in the Real-world Setting.

    abstract:BACKGROUND/AIM:The aim of this report was to summarize the real-world experience with lipegfilgrastim as a neutropenia prophylaxis in a large cohort of lymphoma patients receiving immuno-, chemo-therapy. PATIENTS AND METHODS:Observational clinical data were derived from two phase IV studies (NADIR and LEOS) with simil...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14782

    authors: Pettengell R,Wolff T,Goehler T,Cascavilla N

    更新日期:2021-01-01 00:00:00

  • Noncalcemic Vitamin D Hydroxyderivatives Inhibit Human Oral Squamous Cell Carcinoma and Down-regulate Hedgehog and WNT/β-Catenin Pathways.

    abstract:BACKGROUND/AIM:The hormonally-active form of vitamin D, 1,25(OH)2D3, demonstrated activity against oral squamous cell carcinoma (OSCC). Cytochrome P450scc (CYP11A1)-derived vitamin D hydroxyderivatives, such as 20(OH)D3 and 1,20(OH)2D3, have overlapping beneficial effects with 1,25(OH)2D3 without causing hypercalcemia....

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14216

    authors: Oak ASW,Bocheva G,Kim TK,Brożyna AA,Janjetovic Z,Athar M,Tuckey RC,Slominski AT

    更新日期:2020-05-01 00:00:00

  • Reversing multidrug resistance in L1210 tumor cells by hycanthone or chlorophenoxamine in vitro and in vivo.

    abstract::In the presence study we demonstrated that hycanthone and chlorophenoxamine can modulate the resistance of multidrug resistant (MDR) murine L1210 leukemia tumor lines in vitro and in vivo. The circumvention of MDR by hycanthone and chlorophenoxamine in vitro was demonstrated by a short-term test using tritiated nuclei...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Efferth T,Klett T,Mattern J,Osswald H,Pommerenke EW,Stöhr M,Volm M

    更新日期:1991-05-01 00:00:00

  • Phase I Study of Combination Therapy With Weekly Nanoparticle Albumin-bound Paclitaxel and Cyclophosphamide in Metastatic Breast Cancer Patients.

    abstract:BACKGROUND/AIM:The objective of this phase I study was to determine the maximum-tolerated dose (MTD) and recommended dose (RD) of combination therapy with weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) and cyclophosphamide (CPA) in metastatic breast cancer (MBC) patients. PATIENTS AND METHODS:Five patie...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13910

    authors: Ota D,Akatsuka S,Nishi T,Kato T,Takeuchi M,Tsuji M,Fukuuchi A

    更新日期:2019-12-01 00:00:00

  • The C-Terminus of Hepatitis B Virus-encoded X Protein Is Required for Lapatinib Sensitivity in Hepatocellular Carcinoma Cells.

    abstract:BACKGROUND/AIM:Hepatitis B virus-encoded X protein (HBx) plays a pivotal role in hepatocellular carcinoma (HCC) progression and treatment resistance. Interestingly, our previous study unexpectedly showed that full-length HBx sensitized HCC cells to lapatinib by up-regulating erb-b2 receptor tyrosine kinase 3 (ERBB3). W...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13168

    authors: Chen JY,Huang WC,Wei CT,Chien PH,Chen YJ

    更新日期:2019-02-01 00:00:00

  • Pentafecta Outcomes of 230 Cases of Robotic-assisted Radical Prostatectomy with Bilateral Neurovascular Bundle Preservation.

    abstract:AIM:We analyzed pentafecta outcomes [complication-free, continence, potency, negative surgical margins (NSM)], biochemical recurrence (BCR)-free] of 230 patients undergoing robotic-assisted radical prostatectomy (RARP) with bilateral neurovascular (NVB) preservation. PATIENTS AND METHODS:Patient outcomes (group I, cas...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ou YC,Yang CK,Kang HM,Chang KS,Wang J,Hung SW,Tung MC,Tewari AK,Patel VR

    更新日期:2015-09-01 00:00:00

  • Y-box Binding Protein 1 Is Involved in Regulating the G2/M Phase of the Cell Cycle.

    abstract:BACKGROUND/AIM:The transcription factor Y-box-binding protein 1 (YB1) is overexpressed in many types of human cancers. YB1 regulates the G1 phase of the cell cycle by controlling transcription of G1 regulators. Here, we report that YB1 is also involved in regulating G2/M phase. MATERIALS AND METHODS:YB1-depleted TKO c...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11490

    authors: Kotake Y,Arikawa N,Tahara K,Maru H,Naemura M

    更新日期:2017-04-01 00:00:00

  • Mutant p53 product in patients with stage III cervical cancer.

    abstract::Mutations in the p53 gene stimulate cell division. In our study we assessed the prognostic value of mutant p53 overexpression in cervical cancer stage FIGO III detected by immunohistochemistry. In 43 tissue specimens were detected p53 overexpression in 20 cases. Mean survival time was 36.4 (SE +/- 7.66) months in the ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gitsch G,Kainz C,Joura E,Breitenecker G

    更新日期:1992-11-01 00:00:00

  • A Case of 15-Year Recurrence-free Survival After Microwave Coagulation Therapy for Liver Metastasis from Gastric Cancer.

    abstract::A 70-year-old man with a growing liver tumor had undergone subtotal gastrectomy with pancreaticoduodenectomy for gastric cancer (T4b P0 H0 N1, Stage IIIB) 30 months before admission to our hospital. Enhanced computed tomography revealed two hypervascular nodules in segments 4 and 8. After histological diagnosis of sma...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12389

    authors: Kinoshita K,Beppu T,Miyata T,Kuramoto K,Yoshida Y,Umesaki N,Kitano Y,Nakagawa S,Okabe H,Nitta H,Imai K,Hayashi H,Yamashita YI,Komori H,Horino K,Misumi A,Baba H

    更新日期:2018-03-01 00:00:00

  • Differential expression of VEGF121, VEGF165 and VEGF189 in angiomas and squamous cell carcinoma cell lines of the head and neck.

    abstract::Vascular endothelial growth factor A (VEGF) is one of the major regulators of angiogenesis. It plays an important role during the process of physiological and pathological neovascularization. Variant VEGF isoforms are generated as a result of alternative pre-mRNA splicing. To determine the expression of VEGF isoforms ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cai C,Böttcher MC,Werner JA,Mandic R

    更新日期:2010-03-01 00:00:00

  • 5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study.

    abstract:UNLABELLED:The aim this study was to assess the efficacy of cisplatin-epirubicin-vinorelbine, as primary chemotherapy, in reducing the tumour burden in T2-3 N0-2 breast carcinomas. Breast conservative surgery (BCS) rate, clinical and pathological complete response (pCR), toxicity and 5-year disease-free survival (DFS) ...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Barni S,Visini M,Piazza E,Ionta MT,Ardizzoia A,Arnoldi E,Fava S,Pinotti G,Torretta F,Corradini G,Villa S,Nosenzo AM,Massidda B,Cazzaniga ME

    更新日期:2007-07-01 00:00:00

  • Cyclosporin A Reversed Chemoresistance of a Patient with Pure Red Cell Aplasia Secondary to Thymoma.

    abstract:CASE REPORT:This case study reports on a patient who relapsed with thymoma (mixed type) nine years after tumor resection. After four courses of rescue chemotherapy (docetaxel and cisplatinum), the patient was further diagnosed with pure red cell aplasia. It was noticed that cyclosporin A (CsA), which was administered t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11861

    authors: Li P,Du F,Gong Z,Hu B,Chi C,Chu H,Chen J

    更新日期:2017-08-01 00:00:00

  • Mutual associations between malignancy, age, gender, and subsite incidence of colorectal cancer.

    abstract:BACKGROUND:A cross-sectional study was performed on a cohort of colorectal cancer (CRC) patients to reveal any influence of age, gender, and subsite on grades of malignancy. PATIENTS AND METHODS:Data from histopathological grading according to WHO criteria were pooled into groups of low-grade (well and moderately diff...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Brozek W,Kriwanek S,Bonner E,Peterlik M,Cross HS

    更新日期:2009-09-01 00:00:00

  • MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.

    abstract:BACKGROUND:The clinical significance of the circulating levels of activin A and matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) was investigated in patients with breast cancer (BC) or prostate cancer (PC) with (M1) or without (M0) bone metastasis. PATIENTS AND METHODS:MMP-2, MMP-9 and activin A blood concentrations ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Incorvaia L,Badalamenti G,Rini G,Arcara C,Fricano S,Sferrazza C,Di Trapani D,Gebbia N,Leto G

    更新日期:2007-05-01 00:00:00

  • Relationship Between Preoperative Erythrocyte Sedimentation Rate and Survival After Surgery in Patients with Colorectal Cancer.

    abstract:AIM:To investigate the relationship between erythrocyte sedimentation rate (ESR) and postoperative survival of patients with colorectal cancer (CRC). MATERIALS AND METHODS:Relationships between clinical characteristics and overall survival (OS) of patients with CRC were investigated using multivariate analysis. Receiv...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13049

    authors: Shibuya N,Ishizuka M,Takagi K,Iwasaki Y,Hachiya H,Aoki T,Kubota K

    更新日期:2018-12-01 00:00:00

  • Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer.

    abstract:UNLABELLED:The aim of this study was to evaluate the efficacy and safety of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in Japanese patients with relapsed or recurrent advanced non-small cell lung cancer (NSCLC). PATIENTS AND METHODS:This was a multicentre, open-label phase II study of er...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Takahashi T,Yamamoto N,Nukiwa T,Mori K,Tsuboi M,Horai T,Masuda N,Eguchi K,Mitsudomi T,Yokota S,Segawa Y,Ichinose Y,Fukuoka M,Saijo N

    更新日期:2010-02-01 00:00:00

  • Toxic proteins from European mistletoe (Viscum album L.): increase of intracellular IL-4 but decrease of IFN-gamma in apoptotic cells.

    abstract:BACKGROUND:Mistletoe lectins (ML), the major biologically active components of mistletoe extracts, which are used for adjuvant cancer therapy, induce apoptosis in lymphocytes and tumor cells. In addition, ML at toxic concentrations induce the release of cytokines, but it remains unclear as to whether dying or activated...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Stein GM,Pfüller U,Schietzel M,Büssing A

    更新日期:2000-05-01 00:00:00

  • Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.

    abstract:BACKGROUND/AIM:Salvage androgen-deprivation therapy (ADT) is standard treatment for recurrent prostate cancer after curative therapy. However, the prognostic impact of different treatment modalities on the time to castration resistance remains unclear. In this study, we investigated the prognosis of men treated with sa...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11998

    authors: Obata H,Shiota M,Akitake N,Takeuchi A,Kashiwagi E,Dejima T,Kiyoshima K,Inokuchi J,Tatsugami K,Eto M

    更新日期:2017-10-01 00:00:00

  • Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma; relationship to apoptosis and Bcl-2 protein expression.

    abstract:BACKGROUND:Cyclooxygenase (COX) is a key enzyme in the conversion of arachidonic acid to prostaglandins and other eicosanoids. A recent report has indicated a selective COX-2 inhibitor resulted in increased apoptosis and down-regulated bcl-2 expression in the androgen-sensitive human prostate cancer cell. We investigat...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tanji N,Kikugawa T,Yokoyama M

    更新日期:2000-07-01 00:00:00

  • Clinical efficacy of non-transplant therapies in patients with hepatocellular carcinoma with Child-Pugh C liver cirrhosis.

    abstract:AIM:To compare clinical outcome in patients with Child-Pugh C hepatocellular carcinoma (HCC) treated with non-transplant therapies and those treated with best supportive care. PATIENTS AND METHODS:A total of 182 patients with HCC with Child-Pugh C cirrhosis were analyzed. Patients were classified into two groups: pati...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nishikawa H,Kita R,Kimura T,Ohara Y,Takeda H,Sakamoto A,Saito S,Nishijima N,Nasu A,Komekado H,Osaki Y

    更新日期:2014-06-01 00:00:00

  • Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study.

    abstract:BACKGROUND:Clofarabine is a second-generation nucleoside analogue. The aim of the study was the analysis of ex vivo activity of clofarabine and 14 other anticancer drugs in pediatric and adult acute lymphoblastic (ALL) and myeloid (AML) leukemia. PATIENTS AND METHODS:The ex vivo drug resistance profile was analyzed in...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Styczynski J,Gil L,Derwich K,Wachowiak J,Balwierz W,Badowska W,Krawczuk-Rybak M,Matysiak M,Wieczorek M,Balcerska A,Sonta-Jakimczyk D,Stefaniak J,Kowalczyk J,Urasinski T,Sobol G,Komarnicki M,Wysocki M

    更新日期:2009-05-01 00:00:00

  • Expression of p53 and p21 Ki-ras proteins in rat thyroid gland tumors induced by 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX).

    abstract:BACKGROUND:3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a disinfection by-product in chlorinated drinking water, induces follicular tumors in thyroid glands in Wistar rats. The mechanisms of the MX-induced thyroid gland tumorigenesis are not known. MATERIALS AND METHODS:The expressions of p53 (primary an...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hakulinen P,Kosma VM,Komulainen H

    更新日期:2002-03-01 00:00:00

  • The effects of steroid hormones on a human colon cancer cell line in vitro.

    abstract::Estrogen analogues, moxestrol (10(-8)-10(-5) M) and ethinyl estradiol (10(-8)-10(-6) M), produced a 30% and 15% inhibition of LoVo cell growth, respectively, in serum-free Ham's F-10 medium. Under the same conditions, no growth effects were observed on these cells following the addition of progesterone or testosterone...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lointier P,Wildrick DM,Boman BM

    更新日期:1992-07-01 00:00:00

  • Cytotoxic effect of immunoconjugate composed of glucose-oxidase coupled to an anti-ganglioside (GD2) antibody on spheroids.

    abstract::As a new treatment protocol for neuroblastoma, the chimeric (human/mouse) antiganglioside GD2 antibody chl4.18 is being clinically tested. To improve the therapeutic effect of the antibody alone, we are currently investigating the cytotoxicity of glucose-oxidase coupled to the antibody chl4.18 on spheroids of the neur...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Heiss P,Bernatz S,Bruchelt G,Senekowitsch-Schmidtke R

    更新日期:1997-07-01 00:00:00

  • Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer.

    abstract:PURPOSE:To evaluate the efficacy and safety of oxaliplatin (L-OHP) fractionated over two days with bimonthly 5-fluorouracil (5-FU) and leucovorin (LV), as first-line treatment of metastatic colorectal cancer (MCC) patients. PATIENTS AND METHODS:Fifty-four patients with inoperable MCC (median age, 60 years) were entere...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Recchia F,Rea S,Nuzzo A,Lalli A,Di Lullo L,De Filippis S,Saggio G,Biondi E,Massa E,Mantovani G

    更新日期:2004-05-01 00:00:00

  • Phase II study of topotecan with cisplatin in Japanese patients with small cell lung cancer.

    abstract:BACKGROUND:We conducted a phase II study of topotecan (Tp) with cisplatin (CDDP) in previously untreated Japanese patients with extensive-disease small cell lung cancer (ED-SCLC). PATIENTS AND METHODS:In stage 1, a total of 30 patients were allocated to Tp 0.65 mg/m(2) with CDDP 60 mg/m(2) day 1 or Tp 1.00 mg/m(2) wit...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hosomi Y,Shibuya M,Niho S,Ichinose Y,Kiura K,Sakai H,Takeda K,Kudo S,Eguchi K,Matsui K,Masuda N,Ando M,Watanabe K

    更新日期:2011-10-01 00:00:00

  • Colorectal cancer: seed and soil hypothesis revisited.

    abstract::The local growth and metastatic potential of colorectal cancer is the outcome of a dynamic balance between cancer cells and the immune system, at both a local and systemic level, summarized as the "seed and soil" hypothesis. Until recently, the staging and treatment approaches for colorectal cancer appeared to be orie...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Seretis F,Seretis C,Youssef H,Chapman M

    更新日期:2014-05-01 00:00:00

  • Estrogen Enhances Malignant Phenotypes in Human Salivary Adenoid Cystic Carcinoma Cells.

    abstract:BACKGROUND/AIM:Adenoid cystic carcinoma (SGC) is a common type of salivary gland cancer (SGC). Surgery is the first treatment choice because chemoradiotherapy is usually not effective. Therefore, new treatment modalities are urgently needed. In this study, it was investigated whether the estrogen axis could be a treatm...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Sumida T,Ishikawa A,Kamata YU,Nakano H,Yamada T,Mori Y

    更新日期:2016-06-01 00:00:00

  • Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.

    abstract::To elucidate the rates of appearance of hepatocellular carcinoma (HCC) and the prognosis of alcoholic liver cirrhosis upon infection with hepatitis virus, we retrospectively studied 190 consecutive patients. The patients were divided into three groups based on whether they were exposed either to hepatitis B virus (HBV...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yamanaka T,Shiraki K,Nakazaawa S,Okano H,Ito T,Deguchi M,Takase K,Nakano T

    更新日期:2001-07-01 00:00:00

  • Lack of correlation between P53 expression, BCL-2 expression, apoptosis and ex vivo chemosensitivity in advanced human breast cancer.

    abstract::The relationship between apoptosis and chemosensitivity remains complex. We tested the chemosensitivity of 45 patients with advanced breast cancer (BC) ex vivo against anthracyclines (A: doxorubicin, epirubicin), taxanes (T: paclitaxel, docetaxel), cisplatin (DDP) and CMF and any correlation with the expression of p53...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rein DT,Schöndorf T,Breidenbach M,Janát MM,Weikelt A,Göhring UJ,Becker M,Mallmann P,Kurbacher CM

    更新日期:2000-11-01 00:00:00